Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa
|
|
- Richard Harrison
- 6 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p Vol. 45, No /01/$ DOI: /AAC Copyright 2001, American Society for Microbiology. All Rights Reserved. Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in Pseudomonas aeruginosa DANIEL AUBERT, 1 LAURENT POIREL, 1 JACQUELINE CHEVALIER, 2 SOPHIE LEOTARD, 1 JEAN-MARIE PAGES, 2 AND PATRICE NORDMANN 1 * Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté demédecine Paris-Sud, Le Kremlin-Bicêtre, 1 and INSERM CJF96-06, Faculté demédecine, Marseille, 2 France Received 17 August 2000/Returned for modification 12 January 2001/Accepted 3 March 2001 Pseudomonas aeruginosa clinical isolate SOF-1 was resistant to cefepime and susceptible to ceftazidime. This resistance phenotype was explained by the expression of OXA-31, which shared 98% amino acid identity with a class D -lactamase, OXA-1. The oxa-31 gene was located on a ca. 300-kb nonconjugative plasmid and on a class 1 integron. No additional efflux mechanism for cefepime was detected in P. aeruginosa SOF-1. Resistance to cefepime and susceptibility to ceftazidime in P. aeruginosa were conferred by OXA-1 as well. The most frequent mechanisms of resistance to extendedspectrum cephalosporins in Pseudomonas aeruginosa are derepression of the chromosomal AmpC -lactamase, impermeability of the outer membrane, and increased efflux (5). These various processes, independently or conjointly, confer resistance to ceftazidime. Extended-spectrum -lactamases (ESBLs) belonging to each of the Ambler -lactamase classes are described in P. aeruginosa (20). Among the clavulanic acid-inhibited Ambler class A enzymes, TEM- and SHV-related ESBLs, PER-1 and VEB-1 hydrolyze ceftazidime and cefepime significantly (20). The Ambler class B enzymes, IMP-1, VIM-1, and VIM-2, have the broadest hydrolysis profiles, which include hydrolysis of ceftazidime and cefepime (20, 25). The last group of ESBLs includes OXA-18, the OXA-2 and OXA-10 derivatives (18, 20), and OXA-24 and ARI-1, with the last two also hydrolyzing carbapenems (3, 9). Among the OXA-10 variants, OXA-11, -14, and -19 predominantly compromise the activity of ceftazidime, while OXA-17 mainly degrades cefotaxime (8, 18). The OXA-10 variants confer resistance to cefepime usually at a lower level than they do to ceftazidime. A recent survey conducted with more than 2,000 isolates of P. aeruginosa showed that the rates of susceptibility to ceftazidime and cefepime are similar, being 78.8 to 81.9% and 80 to 83.4%, respectively (27). The aim of the present work was to characterize the mechanism(s) involved in a peculiar antibiotic resistance phenotype that combines resistance to cefepime and susceptibility to ceftazidime. MATERIALS AND METHODS Bacterial strains and plasmids. P. aeruginosa SOF-1 was isolated from a rectal swab specimen from a 1-month-old child hospitalized at the Hôpital de Bicêtre (Le Kremlin-Bicêtre, France) in This isolation was the result of systematic screening for multidrug-resistant gram-negative isolates from patients admitted to the intensive care units of this hospital. It was identified with the API 20 NE system (biomérieux, Marcy l Etoile, France). Ciprofloxacin- or rifampin-resistant * Corresponding author. Mailing address: Service de Bactériologie- Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre cedex, France. Phone: Fax: nordmann.patrice@bct.ap-hop-paris.fr. P. aeruginosa PU21 obtained in vitro and rifampin-resistant Escherichia coli K-12 C600 obtained in vitro were used as recipient strains for conjugation, and E. coli DH10B and P. aeruginosa (Institut Pasteur Collection, Paris, France) reference strains (23 25) were used for cloning experiments. E. coli NCTC carrying plasmids of 154, 66, 38, and 7 kb served as a control in a plasmid-sizing study (33). Plasmids ppcrscript-cam (SK ; Stratagene, Amsterdam, The Netherlands), which carries the chloramphenicol resistance marker, and the E. coli-p. aeruginosa shuttle vector pbbr1mcs, which confers resistance to tetracycline, were used for the cloning experiments (12). Antimicrobial agents and MIC determinations. Antibiotic disks (Sanofi-Diagnostics Pasteur, Marnes-la-Coquette, France) were used for routine antibiograms. The antimicrobial agents were obtained from standard laboratory powders and were used immediately after their solubilization. The agents and their sources were as follows: amoxicillin, ceftazidime, clavulanic acid, and ticarcillin, Glaxo-Smith-Kline (Nanterre, France); amikacin, aztreonam, and cefepime, Bristol-Myers Squibb (Paris-La Défense, France); cephalothin and moxalactam, Eli Lilly (Saint-Cloud, France); piperacillin and tazobactam, Lederle (Oullins, France); sulbactam, Pfizer (Orsay, France); cefotaxime, cefuroxime, and cefpirome, Aventis (Paris, France); cefoxitin and imipenem, Merck Sharp & Dohme- Chibret (Paris, France); and rifampin and chloramphenicol, Sigma (Saint-Quentin Falavier, France). MICs were determined by an agar dilution technique on Mueller-Hinton agar plates with a Steers multiple inoculator and an inoculum of 10 4 CFU per spot (23). Results of susceptibility testing were recorded according to the guidelines of the National Committee for Clinical Laboratory Standards (19) after incubation at 37 C for 18 h. Plasmid DNA analysis. Plasmid DNAs from P. aeruginosa SOF-1 were extracted by two different methods as described previously (23, 25) and with the Qiagen plasmid DNA maxi kit (Qiagen, Courtaboeuf, France). Plasmid DNAs were analyzed by electrophoresis on a 0.7% agarose gel containing 0.5 g of ethidium bromide per ml for 16 h at 90 V (28) and compared to standard sizes of plasmid DNAs of E. coli NCTC The gel was transferred to a nylon membrane (Hybond N ; Amersham Pharmacia Biotech, Orsay, France) by the Southern technique (28). The DNAs were then UV cross-linked (Stratalinker; Stratagene) for 30 s. The probe, made of a PCR-generated, 611-bp internal fragment of bla OXA-31 (see Results section), was labeled with the an ECL nonradioactive labeling and detection kit (Amersham Pharmacia Biotech), based on a combination of enhanced chemiluminescence detection and random primer labeling of DNA. Direct transfer of the ticarcillin and cefepime resistance markers into rifampin-resistant E. coli K-12 C600 or rifampin- or ciprofloxacin-resistant P. aeruginosa PU21 was attempted by liquid and solid mating-out assays at 37 C (25). The antibiotic concentrations for transconjugant selection on Trypticase soy (TS) agar plates (Sanofi-Diagnostics Pasteur) were 50, 20, 200, and 10 g/ml for ticarcillin, cefepime, rifampin, and ciprofloxacin, respectively. Recombinant plasmids were transferred by electroporation into the E. coli DH10B and P. aeruginosa reference strains. Cloning experiments and analysis of recombinant plasmids. Whole-cell DNA of P. aeruginosa SOF-1 was extracted as described previously (23). Since most of 1615
2 1616 AUBERT ET AL. ANTIMICROB. AGENTS CHEMOTHER. the oxacillinase genes are located on a class 1 integron (10, 18), PCR amplification experiments were attempted with primers located in 5 -CS and 3 -CS regions (each end of class 1 integrons) (24) and whole-cell DNA of P. aeruginosa SOF-1 as a template. The fragment of 3.5 kb obtained by PCR was cloned into the SrfI site of ppcrscript Cam (SK ) as described previously (25), and the resulting recombinant plasmid pdan-1 was selected in E. coli DH10B on Mueller-Hinton agar plates containing amoxicillin (50 g/ml) and chloramphenicol (30 g/ml). Then, the oxa-31 gene was subcloned by insertion of a SpeI-PstI fragment of pdan-1 into the SpeI-PstI restricted shuttle vector pbbr1mcs, giving pdan-2. The oxa-1 gene was amplified by PCR (with primer OXA1A [5 -AGCCGTTAAAATTAAGCCC-3 ] and primer OXA1B [5 -CTTGATTGA AGGGTTGGGC G-3 ) with bla OXA-1 -containing plasmid RGN238 from Salmonella enterica serotype Typhimurium as a template (gift from R. Labia) (21). The 911-bp fragment encompassing the oxa-1 gene obtained by PCR was cloned into plasmid pbbr1mcs, giving recombinant plasmid pdan-3. DNA sequencing and protein analysis. Both strands of the cloned DNA fragments from recombinant plasmids pdan-1 and pdna-3 were sequenced with an Applied Biosystems sequencer (model ABI 373). The nucleotide and the deduced protein sequences were analyzed with software available over the Internet at the National Center for Biotechnology Information website (http: // Biochemical analysis. Cultures of E. coli DH10B and P. aeruginosa harboring recombinant plasmids pdan-2 and pdan-3 and cultures of P. aeruginosa SOF-1 were grown overnight at 37 C in 500 ml of TS broth containing ticarcillin (50 g/ml), and -lactamase extracts were obtained as described previously (24). The -lactamase extracts were suspended in 20 ml of Tris 100 mm H 2 SO mm K 2 SO 4 buffer (ph 7.0). The protein content was measured by the Bio-Rad DC Protein assay, and the specific activities of the -lactamase extracts (except for those from the P. aeruginosa SOF-1 culture) were compared as described previously (24). The -lactamase extracts from cultures of E. coli DH10B(pDAN-2 and pdan-3) were further purified by a two-step ultrafiltration as recommended by the manufacturer (Vivapsin, 20 ml; 100,000 MWCOPES and 10,000 MW- COPES; Sartorius, Göttingen, Germany). Purified -lactamase extracts were used for kinetic measurements performed at 30 C in Tris-100 mm H 2 SO mm K 2 SO 4 buffer (ph 7.0). The initial rates of hydrolysis were determined with an ULTROSPEC 2000 UV spectrophotometer (Amersham Pharmacia Biotech), as described previously (24). Enzyme preparations from cultures of P. aeruginosa SOF-1 and the semipurified -lactamases from E. coli DH10B cultures harboring pdan-2 and pdan-3 were also subjected to analytical isoelectric focusing (IEF) analysis as described previously (24). Measurement of norfloxacin and cefepime accumulation. The technique used for the efflux study has been described previously (16, 30). Briefly, exponentialphase P. aeruginosa SOF-1 cells in Luria-Bertani broth (biomérieux) were removed by centrifugation and washed once in 50 mm sodium phosphate buffer (ph 7.0). The pellets were suspended in the same buffer at a density of CFU per ml. Assays were initiated by adding 14 C-norfloxacin (Merck Sharp & Dohme, Rahway, N.J.) or 14 C-cefepime (Bristol-Myers Squibb, Syracuse, N.Y.) at a concentration of 10 g/ml each (1,010 cpm per ml). Samples (100 l each) were removed at set intervals and were immediately filtered through mpore-size Whatman GF/C filters presoaked in phosphate buffer and then washed twice with 5 ml of cold phosphate buffer. The filters were dried at 80 C, and the radioactivity was measured in a Beckman scintillation spectrophotometer. The same experiments were also performed after a 10-min preincubation with the uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Sigma). Nucleotide sequence accession number. The nucleotide sequence of the oxa-31 gene and its class 1 integron has been assigned EMBL database accession number AF FIG. 1. Structure of the class 1 integrons that contain oxa-31 (A) and oxa-1 (B) cassettes. The arrows indicate the transcriptional orientations of the ORFs. RESULTS AND DISCUSSION Susceptibility testing, plasmid DNA analysis of P. aeruginosa SOF-1, and IEF analysis. P. aeruginosa SOF-1 was resistant to cefepime and cefpirome and was susceptible to ceftazidime, imipenem, and aztreonam (Table 1). Addition of clavulanic acid and tazobactam did not significantly decrease the MICs of piperacillin and ticarcillin (Table 1), thus indicating that a Bush group 2b or 2be -lactamase was not involved (4). Antibiotic susceptibility testing by disk diffusion showed that P. aeruginosa SOF-1 was also resistant to amikacin, chloramphenicol, gentamicin, kanamycin, norfloxacin, and tobramycin (data not shown). The low MIC of ceftazidime was consistent with a weak expression of the naturally occurring AmpCtype enzyme (5). Extraction of plasmid DNA from P. aeruginosa SOF-1 gave a ca. 300-kb plasmid that was not transferred by conjugation to ciprofloxacin- and rifampin-resistant P. aeruginosa PU21 or to rifampin-resistant E. coli K-12. It hybridized with an internal probe for the oxa-31 gene prepared by PCR, thus showing the plasmid location of this gene (data not shown). A -lactamase extract of a culture of P. aeruginosa SOF-1 was submitted to IEF analysis and gave two -lactamases with pi values of 7.5 and 8.5, with the latter likely corresponding to an AmpC-type enzyme (data not shown) (34). A -lactamase extract of E. coli DH10B(pDAN-1) gave a pi value of 7.5, as found for P. aeruginosa SOF-1 (data not shown). Cloning, sequencing of the -lactamase gene, and analysis of the surrounding sequences. The cloned fragment of plasmid pdan-1 encoded three open reading frames (ORFs) located downstream of a class 1 integrase gene (Fig. 1). The first ORF was 828 bp and encoded a 276-amino-acid preprotein, named OXA-31. Within the deduced protein of this ORF, a serinethreonine-phenylalanine-lysine tetrad (S-T-F-K) was found at positions 70 to 73 according to the class D -lactamase numbering (DBL) (Fig. 2); it was included in the conserved serine and lysine amino acid residues characteristic of -lactamases that possess a serine active site or penicillin-binding proteins (11). Five elements characteristic of class D -lactamases were found: S-X-V at positions DBL 118 to 120, Y/F-G-X at positions DBL 144 to 146, W-L/I-X-X-X-L-X-I/V at positions DBL
3 VOL. 45, 2001 OXACILLINASE-MEDIATED RESISTANCE TO CEFEPIME 1617 FIG. 2. Comparison of the amino acid sequence of -lactamase OXA-31 to those of OXA-1, OXA-4, and OXA-30. Dashes indicate identical amino acids. The numbering is according to DBL (13). The highlighted boxes indicate conserved regions within class D -lactamases. 164 to 172, Q-X-X-X-L at positions 176 to 180, and lysinethreonine-arginine (K-T-G) at positions 216 to 218 (Fig. 2) (18). The comparison of the bla OXA-31 nucleotide sequence to those of bla OXA-1 and bla OXA-30 identified the following nucleotide substitutions: at position 146, T to C for bla OXA-1 and bla OXA-30 ; at position 202, C to G for bla OXA-1 and bla OXA-30 ; at position 391, G to A for bla OXA-1 and no change for bla OXA-30 ; and at position 621, G to T for bla OXA-1 and bla OXA-30 (21, 31). Compared to OXA-1 and its derivatives OXA-4 and OXA-30, OXA-31 possessed four, two, and three amino acid changes, respectively (Fig. 2) (21, 29, 31). None of the amino acid changes that occurred in the OXA-31 sequence when it was compared to the sequences of OXA-1 from S. enterica serotype Tyhimurium, OXA-4 from P. aeruginosa, and OXA-30 from Shigella flexneri were located at positions characteristic of class D enzymes (Fig. 2). Analysis of the surrounding DNA sequences of bla OXA-31 revealed an ORF located downstream (Fig. 1). It encoded an aminoacyl adenyl transferase (AADA2a) that shared 99% amino acid identity with AADA2 that has been associated with bla PSE-1 from S. enterica serotype Typhimurium (2, 24). This protein conferred resistance to streptomycin and spectinomycin in E. coli DH10B (data not shown). An additional ORF located downstream corresponded to a cmla-like gene that encodes CMLA6 for chloramphenicol resistance and that shared 99% amino acid identity with CMLA1, with only three amino acid changes (data not shown) (1). A structure of a class 1 integron was found surrounding the oxa-31 cassette. The structure consisted of (i) a 5 -CS containing a class 1 integrase gene with its own promoter, P int, (ii) an att11 recombination site, and (iii) a 3 -CS containing qace 1 (Fig. 1). The oxa-31 gene cassette had a core site (5 -GTTGG GC-3 ), an inverse core site (5 -GCCCAAC-3 ), and a 59-base element made up of 108 bp of the sequence downstream of this gene that was identical to that found in the oxa-1 cassette (21). The 182 N-terminal amino acids of the integrase identified from the sequenced part of the corresponding ORF were identical to those found in several class 1 integrons (6, 32). Compared to the corresponding promoter region for bla OXA-1, the P 1 promoter sequence of bla OXA-31 differed by one substitution in the 10 sequence, and the P 2 promoter sequence of the bla OXA-31 integron was probably not functional due to a
4 1618 AUBERT ET AL. ANTIMICROB. AGENTS CHEMOTHER. TABLE 1. MICs of -lactams for P. aeruginosa SOF-1 clinical isolate, P. aeruginosa harboring recombinant plasmids pdan-2 and pdan-3, reference strain P. aeruginosa , E. coli DH10B harboring recombinant plasmids pdan-1, pdan-2, pdan-3, and reference strain E. coli DH10B MIC ( g/ml) for a : -Lactam b P. aeruginosa P. aeruginosa P. aeruginosa P. aeruginosa E. coli SOF (pDAN-2) (pDAN-3) DH10B(pDAN-1) E. coli DH10B(pDAN-2) E. coli DH10B(pDAN-3) E. coli DH10B Amoxicillin Ticarcillin Ticarcillin CLA Piperacillin Piperacillin TZB Cephalothin Cefsulodin Cefuroxime Ceftazidime Ceftazidime CLA Cefotaxime Cefepime Cefpirome Moxalactam Aztreonam Imipenem a The P. aeruginosa SOF-1 clinical isolate and recombinant plasmids pdan-1 and pdan-2 expressed OXA-31, while pdan-3 expressed OXA-1. b CLA, clavulanic acid at a fixed concentration of 2 g/ml; TZB, tazobactam at a fixed concentration of 4 g/ml. shorter spacing (14 bp instead of 17 bp). This promoter pair was identical to the hybrid promoter sequences found in the bla OXA-2 -containing integron (7, 14, 21). Comparison of OXA-31 and OXA-1 activities. The MIC of cefepime for E. coli DH10B(pDAN-1) increased slightly compared to that for E. coli DH10B, while the MICs of ceftazidime remained unchanged and the MICs of cefotaxime were only weakly increased (Table 1). To show that OXA-31 confers resistance to cefepime and susceptibility to ceftazidime, a series of experiments was performed. Recombinant plasmid pdan-2 that contained a bla OXA-31 -containing DNA fragment from pdan-1 was transferred by electroporation into reference strains E. coli DH10B and P. aeruginosa The MICs of cefepime, cefpirome, and ticarcillin were significantly TABLE 2. Specific activities of OXA-31 and OXA-1 from E. coli DH10B and P. aeruginosa Substrate (100 M) Sp act (mu/mg) a E. coli DH10B P. aeruginosa OXA-31 b OXA-1 c OXA-31 OXA-1 Amoxicillin d Aztreonam NH e NH NH NH Cefepime Cefotaxime Cefpirome ,120 1,190 Ceftazidime NH NH NH NH Cephalothin 5 6 Cloxacillin ,720 2,970 a Standard deviations were within 10%. b OXA-31 was expressed from recombinant plasmid pdan-2. c OXA-1 was expressed from recombinant plasmid pdan-3. d, not done due to interference with the naturally occurring AmpC-type cephalosporinase. e NH, no detectable hydrolysis. increased for P. aeruginosa (pDAN-2) compared to those for P. aeruginosa , while the MICs of ceftazidime and cefotaxime remained unchanged or were slightly increased, respectively (Table 1). This experiment clearly established the role of OXA-31 in the acquisition of resistance to cefepime in P. aeruginosa. Recombinant plasmid pdan-3, which had a bla OXA-1 -containing DNA fragment, was transferred by electroporation into reference strains E. coli DH10B and P. aeruginosa The MICs of -lactams for E. coli DH10B harboring pdan-3 (OXA-1) and pdan-2 (OXA-31) on the one hand and for P. aeruginosa harboring pdan-2 and pdan-3 on the other were identical (Table 1). The specific activities of -lactamase extracts for several -lactams were determined with extracts from E. coli DH10B and P. aeruginosa cultures expressing either OXA-31 or OXA-1 (Table 2). The values obtained were almost identical, showing that OXA-1 and OXA-31 had similar hydrolysis spectra for cefepime and cefpirome on the one hand and for ceftazidime and cefotaxime on TABLE 3. Comparison of kinetic parameters of several -lactams for OXA-31 and OXA-1 -Lactam OXA-31 OXA-1 V max a K m ( M) V max /K m V max K m ( M) V max /K m Benzylpenicillin Amoxicillin Cefepime 1, , Cefpirome 1, , Cephalothin Cefotaxime Cloxacillin , a The Vmax values are relative to that of benzylpenicillin, which was set at 100. Standard deviations were within 10%.
5 VOL. 45, 2001 OXACILLINASE-MEDIATED RESISTANCE TO CEFEPIME 1619 FIG. 3. Intracellular accumulation of cefepime and norfloxacin in P. aeruginosa clinical isolate SOF-1. The intracellular concentrations of radiolabeled norfloxacin (A) and cefepime (B) were measured in cells of P. aeruginosa SOF-1 with (F) or without ( ) the energy uncoupler CCCP. Values are means of two independent experiments. the other, although for the last two drugs hydrolysis was weak or undetectable (Table 2). The specific activities obtained from P. aeruginosa cultures were much higher compared to those obtained from E. coli cultures, whatever substrate was used, except for ceftazidime and aztreonam. Increases ranged from 10- to 15-fold according to the substrate, probably as a result of a higher rate of plasmid replication in P. aeruginosa cultures or better -lactamase folding. The results for the cefepime and cefpirome specific activities correlated to the MICs, with a marked increase in the level of resistance in P. aeruginosa (Tables 1 and 2). The hydrolysis parameters for OXA-1 and OXA-31 showed that they are typical oxacillinases (Table 3). Kinetic parameters showed that the catalytic activities of OXA-1 and OXA-31 were similar and were significant toward cefepime (Table 3). Efflux study. The efflux of cefepime has been reported in P. aeruginosa as a resistance mechanism that may be specific to cefepime and cefpirome (26). Thus, the efflux of cefepime was examined as an additional mechanism of resistance to cefepime in P. aeruginosa SOF-1. The levels of norfloxacin and cefepime that accumulated at steady state were compared in the absence or in the presence of the uncoupler CCCP since intracellular uptake is energy independent and efflux is energy dependent. The steady-state level of intracellular norfloxacin increased by about threefold in the presence of CCCP, thus indicating the presence of an efflux mechanism for this drug that paralleled the resistance to norfloxacin observed in P. aeruginosa SOF-1 (Fig. 3A). By contrast, the addition of CCCP did not change the intracellular concentration of cefepime significantly, thus ruling out efflux of this drug in P. aeruginosa SOF-1 (Fig. 3B). Conclusion. We showed that OXA-31 confers resistance to cefepime and susceptibility to ceftazidime in P. aeruginosa SOF-1, a property not reported previously (13). This property is shared by OXA-1 as well and is very likely shared by other OXA-1 derivatives such as OXA-4 (17). Indeed, -lactamase OXA-4, originally described in P. aeruginosa (15, 22) and reported recently from several P. aeruginosa isolates in Japan, confers resistance to the oxyimino cephalosporin cefclidin and susceptibility to ceftazidime (17). Thus, OXA-1 and its derivatives may selectively hydrolyze some 2-amino-5-thiazolyl cephalosporins (cefpirome, cefepime, and cefclidin) and not others (ceftazidime, cefotaxime), with these drugs mostly differing by substitutions at the C-3 of the cephem core. Finally, this study showed that in a routine laboratory ceftazidime resistance should not be reported on the sole basis of cefepime resistance for P. aeruginosa-producing OXA-1 derivatives, as opposed to those that produce class A ESBLs. This result has clinical implications for the choice of the most appropriate treatment for nosocomial infections due to P. aeruginosa. ACKNOWLEDGMENTS This work was funded by a grant from the Ministère de l Education Nationale et de la Recherche (UPRES, grant JE-2227), Université Paris XI, Paris, France; INSERM (grant CJF 96-06), Marseilles, France; and a grant-in-aid from Glaxo-Smith-Kline (from F. Leblanc), Paris, France. We thank M. Malléa for help with the efflux experiments and A. Ladzunski for gift of plasmid pbbr1mcs. REFERENCES 1. Bissonnette, L., S. Champetier, J. P. Buisson, and P. H. Roy Characterization of the nonenzymatic chloramphenicol resistance (cmla) gene of the In4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J. Bacteriol. 173: Bito, A., and M. Susani Revised analysis of aada2 gene of plasmid psa. Antimicrob. Agents Chemother. 38: Bou G., A. Oliver, and J. Martinez-Beltran OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44: Bush, K., G. A. Jacoby, and A. A. Medeiros A functional classification scheme for -lactamases and its correlation with molecular structure. Anti-
6 1620 AUBERT ET AL. ANTIMICROB. AGENTS CHEMOTHER. microb. Agents Chemother. 39: Chen, H. Y., M. Yuan, and D. M. Livermore Mechanisms of resistance to -lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in J. Med. Microbiol. 43: Collis, C. M., and R. M. Hall Expression of antibiotic resistance gene in the integrated cassettes of integrons. Antimicrob. Agents Chemother. 39: Dale, J. W., D. Godwin, D. Mossakowska, P. Stephenson, and S. Wall Sequence of the OXA2 beta-lactamase: comparison with other penicillinreactive enzymes. FEBS Lett. 191: Danel, F., L. M. C. Hall, B. Duke, D. Gur, and D. M. Livermore OXA-17, a further extended-spectrum variant of OXA-10 -lactamase isolated from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43: Donald, H. M., W. Scaife, S. G. Amyes, and H.-K. Young Sequence analysis of ARI-1, a novel OXA -lactamase responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44: Fluit, A. C., and F. J. Schmitz Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18: Joris, B., P. Ledent, O. Dideberg, E. Fonze, J. Lamotte-Brasseur, J. A. Kelly, J. M. Ghuysen, and J.-M. Frère Comparison of the sequences of class A -lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob. Agents Chemother. 35: Kovach, M. E., R. W. Phillips, P. H. Elzer, R. M. Roop II, and K. M. Peterson pbbr1mcs: a broad-host range cloning vector. BioTechniques 16: Ledent, P., X. Raquet, B. Joris, J. Van Beeumen, and J.-M. Frère A comparative study of class-d -lactamases. Biochem. J. 292: Lévesque, C., S. Brassard, J. Lapointe, and P. H. Roy Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 142: Lévesque, R. C., A. A. Medeiros, and G. A. Jacoby Molecular cloning and DNA homology of plasmid-mediated -lactamase genes. Mol. Gen. Genet. 206: Malléa, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J.-M. Pagès Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144: Marumo, K., A. Takeda, Y. Nakamura, and K. Nakaya Detection of OXA-4 -lactamase in Pseudomonas aeruginosa isolates by genetic methods. J. Antimicrob. Chemother. 43: Naas, T., and P. Nordmann OXA-type -lactamases. Curr. Pharm. Design 5: National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7 A4. National Committee for Clinical Laboratory Standards, Wayne, Pa. 20. Nordmann, P., and M. Guibert Extended-spectrum -lactamases in Pseudomonas aeruginosa J. Antimicrob. Chemother. 42: Ouellette, M., L. Bissonnette, and P. H. Roy Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 -lactamase genes. Proc. Natl. Acad. Sci. USA 84: Philippon, A. M., G. C. Paul, and G. A. Jacoby New plasmid-mediated oxacillin-hydrolyzing -lactamase in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 17: Philippon, L. N., T. Naas, A.-T. Bouthors, V. Barakett, and P. Nordmann OXA-18, a class D clavulanic acid-inhibited extended-spectrum -lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41: Poirel, L., M. Guibert, S. Bellais, T. Naas, and P. Nordmann Integronand carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 from French patients. Antimicrob. Agents Chemother. 43: Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann Characterization of VIM-2, a carbapenem-hydrolyzing metallo- -lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44: Poole, K., N. Gotoh, H. Tsujimot, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. Yamagishi, X. Z. Li, and T. Nishino Overexpression of the mexcmexd-oprj efflux operon in nfxb-type multidrug resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21: Ramphal, R., D. J. Hoban, M. A. Pfaller, and R. J. Jones Comparison of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY antimicrobial surveillance program, Diagn. Microbiol. Infect. Dis. 36: Sambrook, J., E. F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 29. Sanschagrin, F., F. Couture, and R. C. Lévesque Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D beta-lactamases. Antimicrob. Agents Chemother. 39: Simonet, V., M. Malléa, and J.-M. Pagès Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel. Antimicrob. Agents Chemother. 44: Siu, L. K., J. Y. Lo, K. Y. Yuen, P. Y. Chau, M. H. Ng, and P. L. Ho Lactamases in Shigella flexneri isolates from Hong Kong and Shangai and a novel OXA-1-like -lactamase, OXA-30. Antimicrob. Agents Chemother. 44: Stokes, H. W., D. B. O Gorman, G. D. Recchia, M. Parsekhian, and R. M. Hall Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol. Microbiol. 26: Vivian, A Plasmid expansion? Microbiology 140: Walther-Rasmussen, J., A. H. Johnsen, and N. Hoiby Terminal truncations in AmpC -lactamase from a clinical isolate of Pseudomonas aeruginosa. Eur. J. Biochem. 363:
OXA-28, an Extended-Spectrum Variant of OXA-10 -Lactamase from Pseudomonas aeruginosa and Its Plasmid- and Integron-Located Gene
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2001, p. 447 453 Vol. 45, No. 2 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.2.447 453.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationJAC A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa
Journal of Antimicrobial Chemotherapy (2002) 49, 561 565 JAC A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum β-lactamase GES-2 in South Africa Laurent Poirel a,
More informationIS1999 Increases Expression of the Extended-Spectrum -Lactamase VEB-1 in Pseudomonas aeruginosa
JOURNAL OF BACTERIOLOGY, Sept. 2003, p. 5314 5319 Vol. 185, No. 17 0021-9193/03/$08.00 0 DOI: 10.1128/JB.185.17.5314 5319.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. IS1999
More informationOXA-18, a Class D Clavulanic Acid-Inhibited Extended-Spectrum -Lactamase from Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1997, p. 2188 2195 Vol. 41, No. 10 0066-4804/97/$04.00 0 Copyright 1997, American Society for Microbiology OXA-18, a Class D Clavulanic Acid-Inhibited Extended-Spectrum
More informationGES-2, a Class A -Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2001, p. 2598 2603 Vol. 45, No. 9 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.9.2598 2603.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationAAC Accepts, published online ahead of print on 2 June 2008 Antimicrob. Agents Chemother. doi: /aac
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:.11/aac.00175-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationBEL-1, a Novel Clavulanic Acid-Inhibited Extended-Spectrum -Lactamase, and the Class 1 Integron In120 in Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2005, p. 3743 3748 Vol. 49, No. 9 0066-4804/05/$08.00 0 doi:10.1128/aac.49.9.3743 3748.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationCharacterization of a Naturally Occurring Class D -Lactamase from Achromobacter xylosoxidans
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2008, p. 1952 1956 Vol. 52, No. 6 0066-4804/08/$08.00 0 doi:10.1128/aac.01463-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Characterization
More informationCloning and Characterization of E. meningoseptica Beta Lactamase
Cloning and Characterization of E. meningoseptica Beta Lactamase Authors: Lindsey Purcell, Jessica Matts, Patricia Canaan* Department of Biochemistry and Molecular Biology Abstract Elizabethkingia meningoseptica
More informationEmergence and persistence of integron structures harbouring VIM genes in the Children s Memorial Health Institute, Warsaw, Poland,
Journal of Antimicrobial Chemotherapy (2009) 63, 269 273 doi:10.1093/jac/dkn512 Advance Access publication 18 December 2008 Emergence and persistence of integron structures harbouring VIM genes in the
More informationGenetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type ß-Lactamase, RTG-4, from Acinetobacter baumannii
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 2009, p. 3010 3016 Vol. 53, No. 7 0066-4804/09/$08.00 0 doi:10.1128/aac.01164-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Genetic
More informationEvaluation of the Osiris Expert System for Identification of -Lactam Phenotypes in Isolates of Pseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2003, p. 3712 3718 Vol. 41, No. 8 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.8.3712 3718.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationMolecular Characterization of OXA-20, a Novel Class D -Lactamase, and Its Integron from Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1998, p. 2074 2083 Vol. 42, No. 8 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Molecular Characterization of
More informationResistance, Yonsei University College of Medicine, Seoul, Korea; and 2 Department of
AAC Accepts, published online ahead of print on March 0 Antimicrob. Agents Chemother. doi:./aac.0- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationWhen Carbapenem-Hydrolyzing ß-Lactamase KPC. attributed to outer-membrane protein deficiency coupled with plasmid-mediated
AAC Accepts, published online ahead of print on 18 July 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.00719-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationSequences of -Lactamase Genes Encoding CTX-M-1 (MEN-1) and CTX-M-2 and Relationship of Their Amino Acid Sequences with Those of Other -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1996, p. 509 513 Vol. 40, No. 2 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Sequences of -Lactamase Genes Encoding CTX-M-1 (MEN-1)
More informationSUMMARY. Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M,
SUMMARY Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M, The doctoral thesis entitled Prevalence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBL) isolated from broilers
More informationOXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan
OXA-type J Microbiol ESBLs Immunol in P. Infect aeruginosa 2006;39:130-134 OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital
More informationTRANSMISSIBLE GENETIC ELEMENTS: PLASMIDS, TRANSPOSONS & INTEGRONS
TRANSMISSIBLE GENETIC ELEMENTS: PLASMIDS, TRANSPOSONS & INTEGRONS MOBILE GENETIC ELEMENTS 1 PLASMIDS -MOST OFTEN CIRCULAR MOLECULES OF DOUBLE-STRANDED DNA -VARY WIDELY IN SIZE -SELF-TRANSMISSIBLE ELEMENTS
More informationDetection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India
Detection and characterization of extended spectrum β-lactamase producing Escherichia coli from poultry of eastern India Dr. Samiran Bandyopadhyay Scientist Indian Veterinary Research Institute Eastern
More informationAntimicrobial Agents and Chemotherapy New Data Letter
AAC Accepted Manuscript Posted Online 15 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01519-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 Antimicrobial Agents
More informationExtended Spectrum β-lactamases: Critical Tools of Bacterial Resistance
Review Article Mahidol University Journal of Pharmaceutical Science 2012; 39 (1), 1-8 Extended Spectrum β-lactamases: Critical Tools of Bacterial Resistance Department of Microbiology, Faculty of Pharmacy,
More informationNosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit
Available online at www.annclinlabsci.org 297 NosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit Yang-Ree Kim, 1 Sang-Il Kim, 1
More informationWELCOME. to the CDS WORKSHOP
WELCOME to the CDS WORKSHOP Sydney 2010 Excel Spreadsheet for Registration Recent Additions to the CDS Doripenem 10mg disc A carbapenem claimed to be more active against Pseudomonas than Meropenem Daptomycin:
More informationGenetic support of Extended- Spectrum ß-Lactamases
Genetic support of Extended- Spectrum ß-Lactamases Laurent Poirel Dept of Microbiology (Pr Nordmann) Bicêtre Hospital. South-Paris Medical School. France ESCMID Conference on ESBL 29-31 May 2006 TEM-like
More informationThe biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush
International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.
More informationReceived 23 December 2010/Returned for modification 11 January 2011/Accepted 7 February 2011
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1608 1613 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02607-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Evaluation
More informationPrevalence of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa from King Abdulaziz University Hospital in Jeddah
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationMolecular Epidemiology of the Integron-Located VEB-1 Extended-Spectrum -Lactamase in Nosocomial Enterobacterial Isolates in Bangkok, Thailand
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2001, p. 175 182 Vol. 39, No. 1 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.1.175 182.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Molecular
More informationMolecular and Biochemical Characterization of OXA-45, an Extended-Spectrum Class 2d -Lactamase in Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 2003, p. 2859 2863 Vol. 47, No. 9 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.9.2859 2863.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationOXA-198, an Acquired Carbapenem-Hydrolyzing Class D -Lactamase from Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2011, p. 4828 4833 Vol. 55, No. 10 0066-4804/11/$12.00 doi:10.1128/aac.00522-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. OXA-198,
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationEvaluation of the NCCLS Extended-Spectrum -Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE
JOURNAL OF CLINICAL MICROBIOLOGY, July 2003, p. 3142 3146 Vol. 41, No. 7 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.7.3142 3146.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationReceived 19 May 2000/Returned for modification 24 August 2000/Accepted 17 November 2000
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2001, p. 546 552 Vol. 45, No. 2 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.2.546 552.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationOngoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey
Journal of Antimicrobial Chemotherapy (2008) 61, 59 63 doi:10.1093/jac/dkm443 Advance Access publication 13 November 2007 Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece:
More informationThe Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics in Klebsiella pneumoniae isolates from clinical samples and plasmid curing
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 11:557-561 The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics
More informationMolecular Cell Biology - Problem Drill 11: Recombinant DNA
Molecular Cell Biology - Problem Drill 11: Recombinant DNA Question No. 1 of 10 1. Which of the following statements about the sources of DNA used for molecular cloning is correct? Question #1 (A) cdna
More informationIdentification of Beta-Lactamase Enzymes and Prediction of Successful Beta-Lactam Therapy
JOURNAL OF CLINICAL MICROBIOLOGY, May 1983, p. 791-798 95-1137/83/5791-8$2./ Copyright C 1983, American Society for Microbiology Vol. 17, No. 5 Relative Substrate Affinity Index Values: a Method for Identification
More informationDissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan
Journal of Antimicrobial Chemotherapy (2009) 64, 1170 1174 doi:10.1093/jac/dkp341 Advance Access publication 22 September 2009 Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively
More informationReceived 5 June 2010/Returned for modification 27 June 2010/Accepted 6 August 2010
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 2010, p. 4575 4581 Vol. 54, No. 11 0066-4804/10/$12.00 doi:10.1128/aac.00764-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Emergence
More informationDetection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli
ISSN: 2319-7706 Volume 2 Number 8 (2013) pp. 196-205 http://www.ijcmas.com Original Research Article Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia
More informationPrevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype
J Antimicrob Chemother 2010; 65: 460 464 doi:10.1093/jac/dkp484 Advance publication 22 January 2010 Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC
More informationScreening for Resistant Organisms and Infection Control
Screening for Resistant Organisms and Infection Control Dr Sonal Saxena Professor Department of Microbiology Lady Hardinge Medical College New Delhi 1 MDRO The proportion of K. pneumoniae and E. coli with
More information1. Procedure for Antibiotic susceptibility test by disc diffusion analysis
Nanoparticles Functionalized with Ampicillin Destroy Multiple Antibiotic Resistant Isolates of Pseudomonas aeruginosa, Enterobacter aerogenes and Methicillin Resistant Staphylococcus aureus Ashley Brown
More informationRuning title: identification of a new carbapenem-hydrolyzing class D β-lactamase
AAC Accepts, published online ahead of print on 25 July 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.00522-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationCephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01320.x Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii C. Héritier, L. Poirel and P. Nordmann Service de Bactériologie-Virologie,
More informationReceived 30 October 2003/Returned for modification 28 January 2004/Accepted 14 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3086 3092 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3086 3092.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationComparative Characterization of the Cephamycinase bla CMY-1 Gene and Its Relationship with Other -Lactamase Genes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1996, p. 1926 1930 Vol. 40, No. 8 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Comparative Characterization of the Cephamycinase bla
More informationBeta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology,
More informationREVIEW. Genetic support of extended-spectrum b-lactamases L. Poirel, T. Naas and P. Nordmann
REVIEW Genetic support of extended-spectrum b-lactamases L. Poirel, T. Naas and P. Nordmann Service de Bactériologie-Virologie, Hôpital de Bicêtre, South-Paris Medical School, University Paris XI, Le Kremlin-Bicêtre,
More informationReceived 16 September 2005/Accepted 20 September 2005
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2005, p. 5945 5949 Vol. 43, No. 12 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.12.5945 5949.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationExtended-Spectrum -Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2001, p. 933 951 Vol. 14, No. 4 0893-8512/01/$04.00 0 DOI: 10.1128/CMR.14.4.933 951.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Extended-Spectrum
More informationACCEPTED. Laboratory Medicine, Kosin University College of Medicine, , 34 Amnam-Dong,
AAC Accepts, published online ahead of print on 21 May 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.00279-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationJ. Appl. Environ. Biol. Sci., 5(12) , , TextRoad Publication
J. Appl. Environ. Biol. Sci., 5(2)262-268, 205 205, TextRoad Publication ISSN: 2090-4274 Journal of Applied Environmental and Biological Sciences www.textroad.com Study of routine antibiotic Resistance
More informationSME-Type Carbapenem-Hydrolyzing Class A -Lactamases from Geographically Diverse Serratia marcescens Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 2000, p. 3035 3039 Vol. 44, No. 11 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. SME-Type Carbapenem-Hydrolyzing
More informationThe GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity
Promega Notes Magazine Number 62, 1997, p. 02 The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity By Christine Andrews and Scott Lesley Promega
More informationVIM-19, a Metallo- -Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2010, p. 471 476 Vol. 54, No. 1 0066-4804/10/$12.00 doi:10.1128/aac.00458-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. VIM-19,
More informationMolecular susceptibility testing
Molecular susceptibility testing Dr Andrew Ginn Supervising Scientist Antimicrobial Resistance Reference Laboratory ICPMR, Westmead Hospital Resistance genes Gram negatives Transmissible; e.g. ESBLs, MBLs,
More informationMutagenesis for Studying Gene Function Spring, 2007 Guangyi Wang, Ph.D. POST103B
Mutagenesis for Studying Gene Function Spring, 2007 Guangyi Wang, Ph.D. POST103B guangyi@hawaii.edu http://www.soest.hawaii.edu/marinefungi/ocn403webpage.htm Overview of Last Lecture DNA microarray hybridization
More informationJAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases
Journal of Antimicrobial Chemotherapy (1999) 43, 23 29 JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02030.x Metallo-b-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya J. D. D. Pitout 1,2,3, G. Revathi 4, B. L Chow 1, B.
More informationUse of Bioinformatics to Investigate β-lactamase, a Mediator of β-lactam Antibiotic Resistance
Use of Bioinformatics to Investigate β-lactamase, a Mediator of β-lactam Antibiotic Resistance Paula Lessem Director of Biological Sciences University of Richmond Biology Department Richmond, VA 23173
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationOriginal Article Detection of integrons in Escherichia coli producing plasmid-mediated AmpC β-lactamases
Int J Clin Exp Med 2019;12(2):1690-1696 www.ijcem.com /ISSN:1940-5901/IJCEM0079457 Original Article Detection of integrons in Escherichia coli producing plasmid-mediated AmpC β-lactamases Juanjuan Ding,
More informationCurriculum Vitae. Abbas Maleki, Ph.D. Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
Curriculum Vitae Abbas Maleki, Ph.D Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran E-mail: abbasmaleki_ilam@yahoo.com maleki-a@medilam.ac.ir Tel: +989187419401 Personal
More informationVARIABLE GENE CASSETTE PATTERNS OF CLASS 1 INTEGRON-ASSOCIATED DRUG-RESISTANT ESCHERICHIA COLI IN TAIWAN
VARIABLE GENE CASSETTE PATTERNS OF CLASS 1 INTEGRON-ASSOCIATED DRUG-RESISTANT ESCHERICHIA COLI IN TAIWAN Lin-Li Chang, Tsung-Ming Chang, and Chung-Yu Chang Department of Microbiology, Faculty of Medicine,
More informationORIGINAL ARTICLE /j x. Stroger Jr Hospital, Rush University, Chicago, IL, USA
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01674.x Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa V. H. Tam 1,2, A. N. Schilling 1, M. T. LaRocco 2, L. O. Gentry 2,
More informationAn estimate of the physical distance between two linked markers in Haemophilus influenzae
J. Biosci., Vol. 13, No. 3, September 1988, pp. 223 228. Printed in India. An estimate of the physical distance between two linked markers in Haemophilus influenzae Ε. Β. SAMIWALA, VASUDHA P. JOSHI and
More informationCarbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2002, p. 3817 3822 Vol. 46, No. 12 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.12.3817 3822.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationLecture Four. Molecular Approaches I: Nucleic Acids
Lecture Four. Molecular Approaches I: Nucleic Acids I. Recombinant DNA and Gene Cloning Recombinant DNA is DNA that has been created artificially. DNA from two or more sources is incorporated into a single
More informationNew integron-associated gene cassette encoding a trimethoprim-resistant DfrB-type dihydrofolate reductase
University of Wollongong Research Online Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 2006 New integron-associated gene cassette encoding a trimethoprim-resistant DfrB-type
More informationH. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu
Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province,
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationRole of inducers in detection of bla PDC resistance in Pseudomonas aeruginosa
Indian J Med Res 145, May 2017, pp 659-664 DOI: 10.4103/ijmr.IJMR_628_15 Quick Response Code: Role of inducers in detection of bla PDC -mediated oxyiminocephalosporin resistance in Pseudomonas aeruginosa
More informationTransferable Cefoxitin Resistance in Enterobacteria from Greek Hospitals and Characterization of a Plasmid-Mediated Group 1 -Lactamase (LAT-2)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1996, p. 1736 1740 Vol. 40, No. 7 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Transferable Cefoxitin Resistance in Enterobacteria
More informationAntimicrobial Susceptibility Testing Disk Diffusion
Antimicrobial Susceptibility Testing Disk Diffusion Babak Valizadeh,DCLS Babak_Valizadeh@hotmail.com 1390 / 09 / 10 2011.12.01 1 2 3 CLSI - M02-A10 / 2009 4 CLSI M100-S21 / 2011 Antimicrobial Susceptibility
More informationCombatting AMR: diagnostics
Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International
More informationAntibiotic resistance genes located in integrons isolated from Escherichia coli recovered from humans and animals
University of Wollongong Research Online University of Wollongong Thesis Collection 1954-2016 University of Wollongong Thesis Collections 2009 Antibiotic resistance genes located in integrons isolated
More informationIdentification of plasmid- and integron-borne bla IMP-1 and bla IMP-10 in clinical isolates of Serratia marcescens
Journal of Medical Microbiology (2009), 58, 217 221 DOI 10.1099/jmm.0.006874-0 Identification of plasmid- and integron-borne bla IMP-1 and bla IMP-10 in clinical isolates of Serratia marcescens Zhuting
More informationgenerated by the usage of antimicrobial drugs is absent. She is the author of 14 publications in international journals.
Fernando Baquero Doctor in Medicine, Ramón y Cajal Research Professor in Bacterial Evolution at the Biomedical Research Foundation and Department of Microbiology of the Ramón y Cajal Universty Hospital.
More informationEBR-1, a Novel Ambler Subclass B1 -Lactamase from Empedobacter brevis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2002, p. 3223 3227 Vol. 46, No. 10 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.10.3223 3227.2002 Copyright 2002, American Society for Microbiology. All Rights
More informationAccurate and Timely Identification of Genes Conferring Resistance to Carbapenems Serves as an Important Tool for Infection Control Measures
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.296
More informationSupplementary Methods. Bacterial strains and plasmids. Transconjugants 4-3, 7-24, 10-2, 10-5, 12-5, 29-11, and
Supplementary Methods Bacterial strains and plasmids. Transconjugants 4-3, 7-24, 10-2, 10-5, 12-5, 29-11, and 76-65 all contained single plasmids from clinical isolates of Escherichia coli collected at
More informationChromosome-Encoded Extended-Spectrum Class A β-lactamase MIN-1. from Minibacterium massiliensis
AAC Accepts, published online ahead of print on 23 April 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.06401-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Chromosome-Encoded
More informationCRE Laboratory Testing and CRE Lab Testing Recommendations in-depth recommendations on CRE laboratory detection
December 2014 Dear Laboratory Director, The Illinois Department of Public Health (IDPH) amended the Control of Communicable Diseases Code (77 Ill. Adm. Code 690) to require reporting of Carbapenem-Resistant
More information*Kotgire Santosh A and Tankhiwale Nilima. Sciences University Sawangi(M) Wardha, Maharashtra, India *Author for Correspondence
PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF METALLO-β-LACTAMASES (M-β-L) PRODUCING PSEUDOMONAS AREUGINOSA FROM RURAL HOSPITAL: COMPARISON OF TWO DISK DIFFUSION METHODS *Kotgire Santosh A and
More informationCuring antibiotic resistance in vivo. Muhammad Kamruzzaman
Curing antibiotic resistance in vivo Muhammad Kamruzzaman Occurrence of resistance -Some bacteria are naturally resistant to certain antibiotics -Gene mutation -Horizontal transfer of antibiotic resistance
More informationCharacterization of DIM-1, an Integron-Encoded Metallo-ß- Netherlands
AAC Accepts, published online ahead of print on March 0 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationDepartment of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & *
Indian J Med Res 122, October 2005, pp 330-337 Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Quan J, Li X, Chen Y, et al. Prevalence of
More informationOccurrence and Detection of AmpC β-lactamases among Enterobacteriaceae in a Tertiary Care Centre in Trivandrum, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.023
More informationJOHN DEMPSEY HOSPITAL Farmington, Connecticut ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates
JOHN DEMPSEY HOSPITAL Farmington, Connecticut 2017 ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates **GROUPED BY CULTURE SOURCES** (data from 1/1/17 1/1/18) Prepared by: UCHC/JDH Antimicrobial
More informationFaecal prevalence of extended-spectrum ß-lactamase (ESBL)- producing coliforms in a geriatric population and among haematology patients
Malaysian J Pathol 2005; 27(2) : 75 81 FAECAL ESBL-PRODUCING COLIFORMS Faecal prevalence of extended-spectrum ß-lactamase (ESBL)- producing coliforms in a geriatric population and among haematology patients
More informationSusceptibility Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1982, p. 213-217 Vol. 16, No. 2 0095-1137/82/080213-05$02.00/0 In Vitro Studies with Cefotaxime: Disk Diffusion Susceptibility Tests SMITH SHADOMY* AND EDWARD L.
More informationPhenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates
Phenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates Mohammad Mohammadzadeh 1*, Mahnaz Tavakoli 1, Abolfazl Mohebi 2, Samad Aghayi 2 1 Department
More informationApplication Note INTRODUCTION
Application Note 20 A microtiter-based assay for the determination of ID 50 s of β-lactamase inhibitors employing reporter substrates detected at UV or visible wavelengths INTRODUCTION β-lactamases are
More informationSupporting Information-Tables
Supporting Information-Tables Table S1. Bacterial strains and plasmids used in this work Bacterial strains Description Source of reference Streptococcus pneumoniae 1 Cp1015 non-capsulated and βl susceptible
More informationDetection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel
Journal of Antimicrobial Chemotherapy (2009) 64, 718 722 doi:10.1093/jac/dkp272 Advance Access publication 4 August 2009 Detection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from
More informationTitle: Description of the First Escherichia coli Clinical Isolate Harboring Colistin-
AAC Accepted Manuscript Posted Online 24 October 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01945-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Title: Description
More information